
Pharmaceutical Executive · Yesterday · 3 min
Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience
0:00-3:15
transcript
show notes
In today's Pharmaceutical Executive Daily, Jazz Pharmaceuticals agrees to acquire Actio Biosciences, Novo Nordisk, Innate Pharma, and Innovent Biologics strike a trio of new partnerships, and a Veeva executive discusses how agentic AI is surfacing HCP insights that traditional field reporting has historically missed.
